HYPERPLASTIC alveolar nodules have been shown to represent the preneoplastic state in mouse mammary tumour development (Bern and Nandi, 1961 (Haran-Ghera, 1961) . This failure could, however, be overcome by stimulating the mammary glands with increased prolactin secretion which induced hyperplastic nodules in this tissue. Simultaneous action of the carcinogen and mammary gland stimulation were foumd to induce preneoplastic lesions that eventually developed in intact LAF1 mice into autonomous mammary tumours (Haran-Ghera, 1963 ).
HYPERPLASTIC alveolar nodules have been shown to represent the preneoplastic state in mouse mammary tumour development (Bern and Nandi, 1961) . With little or no mammary gland substrate (due to the inherited hormonal pattern), neither nodules nor tumours arise unless an appropriate level of activity is artificially induced in the tissue.
LAF1 mice (generally considered to be free of the mammary tumour agent), had previously been shown to be refractory to methylcholanthrene mammary carcinogenesis (Haran-Ghera, 1961) . This failure could, however, be overcome by stimulating the mammary glands with increased prolactin secretion which induced hyperplastic nodules in this tissue. Simultaneous action of the carcinogen and mammary gland stimulation were foumd to induce preneoplastic lesions that eventually developed in intact LAF1 mice into autonomous mammary tumours (Haran-Ghera, 1963) .
The present experiments were set up on the basis of these findings, in order to determine the hormonal requirements for further neoplastic transformation of the preneoplastic lesions.
The questions raised were the following: (a) whether mammary gland stimulation was only needed during the period of methylcholanthrene application or throughout the process? (b) whether further development of the induced preneoplastic lesions towards malignancy was dependent on the presence of ovarian and/or adrenal hormones in the host mice? and (c) if such a dependency on hormones did exist, whether a second exogenous hormonal stimulation would enhance the further development of the preneoplastic induced lesions?
LAF1 virgin female mice used in the previous experiments were found to have a low degree of mammary gland substrate. It seemed desirable, therefore, to carry out the present experiments in two strains of mice having a different degree of mammary gland activity. DBA/2 mice (also considered to be free of the mammary tumour agent), which showed a more stimulated mammary gland tissue, were chosen as the second strain for the present studies.
MATERIALS AND METHODS
Female mice of the LAF1-(C57L x A/He) F1 and DBA/2 strains, inbred in our laboratory, were used in these experiments when about 6-8 weeks old. The mice were housed in an air-conditioned room at 21-23°C., and fed on Purina Laboratory Chow and water ad libitum. All mice were checked for palpable tumours once a month, killed when a tumour was observed, or kept until natural death.
Maammary gland stimulation was induced by transplantation of a single isologous pituitary, taken from male or female donors 2-3 months old, beneath the left kidney capsule. This was based on the established evidence by Desclin (1950) and Everett (1954) that suclh a pituitary. when disconnected from the lhypothalamits and transplanted to another site in the body, continues to secrete mainlv prolactini, eliciting both a mammotropic effect, expressed by marked mammarv gland stimulation, and a luteotropic effect, as manifested by a continuous dioestrus cycle. W"hen the hormonal stimulation was intended to act for a limited period, the transplainted pituitary was removed by excising the whole left kidney.
MIethylcholanthrene was administered as a 0.250/0 solution in acetone, applied 6 times to the skin at fortnightly intervals (each painting applied to a different area of skin). the treatment starting 10 days after the pituitary implantation, for 12 wI-eeks. Ten days after the last methylcholanthrene application the pituitary isograft was removed, or allowed to remain in situ for varying periods in other cases.
The bilaterally adrenalectomized mice were maintained oln 0)5 per cent sodium chloride in their drinking water ad libitum, and subsequently given intramuscular injections of 1 mg. percorteii (deoxycorticosterone trimethylacetate) every 4 w%veeks.
Functional mammotropic pituitary tumours (MtT), originally obtained from lr. J. Furth and maintained by us, were used as a source of prolactin in ovariectomized mice. MtT was grafted subcutaneously in the back of the host and partially resected at sllitab)le intervals to prevent it from killing the host.
RESULTS

Ma1amnmary tumour induction in LAF1 and DBA 2 mnice
The development of mammary tumours in LAF1 and )BA 2' mice is summarized in Table I . A comparative study of the oestrus cycle The different reactivity of the two strains of mice to the carcinogenic action of methylcholanthrene could indicate a different inherited hormonal pattern in these strains, by causing different degrees of mammary gland substrate development a critical factor in tumour induction by the carcinogen. Mammary gland stimulation is induced through the action of oestrogens on the pituitary mammotropes (Lyons, Li and Johnson, 1958) . The different degree of mammlary gland stimulation in LAF1 and DBA,/2 mice could thus be due to a different rate of oestrogen secretion in these strains. This was examined by studying the oestrus cycle in normal LAF1 and DBA/2 mice, using the vaginal smear evaluation.
In IDBA/2 mice, 15 of 20 mice examined revealed a normal oestrus cvcle lasting 4-6 days. In LAF1 mice, only 7 of 20 mice examined showed a 4-7 day oestrus cycle, with a prolongation of dioestrus for 8-10 days in the remaining animals. The vaginal smears in LAF1 mice carrying an intrarenal isologous pituitary graft were also recorded. Several days after this implantation, the oestrus cycle disappeared almost completely, and a continuous dioestrous phase was recorded for as long as the host carried the pituitary isograft. A normal oestrus cycle in the host was noted 3-4 days after the isograft was removed.
The role of mammary gland stimulation LAF1 mice received an intrarenal pituitary implant; 10 days later the miiice carrying the implant received methylcholanthrene (MC) treatment for 12 Meeks. The mice were then divided into three groups. In the first group, the implant was removed from the host 10 days after the last MC apDlication; in the second group, the implant was left in situ for 6 months, i.e. removed 3 months after the last MC application; and in the third group, the implant was left in situ throughout life. Parallel controls of pituitary intrarenal implants for different periods were also set up.
As seen in Table II , a similar incidence of mammary tumours (57 per cent) occurred whether mammary gland stimulation was maintained throughout life as compared with the limited period of the concurrent action with the carcinogen (46 per cent). Both 6 months and life-long stimulations did not affect the average latent period of tumour development.
Continuous mammary gland stimulation throughout life without additional carcinogen treatment induced mamimary tumours in 13.6 per cent of LAF1 mice carrying the intrarenal pituitary isograft and shortening of the period of extra mammary gland stimulation reduced this tumour incidence. The effect of ovariectomy and adrenalectomy on the development of the preneoplastic lesions Preneoplastic lesions were induced in LAF1 and DBA/2 mice by the concurrent action of mammary gland stimulation by intrarenal pituitary isograft and methylcholanthrene treatment for 3 months. The mice were then divided into three groups: In group 1, the pituitary implant was removed 10 days after the last MC application; in group 2, the implant and both ovaries were removed at the same time; and in group 3, a triple operation was performed involving the removal of the pituitary implant, both ovaries and both adrenals. As seen in Table III and Fig. 1 , the removal of the ovaries and adrenals or of the ovaries alone inhibited mammary tumour development in LAF1 mice-a 6 per cent incidence of mammary tumours in castrated mice or double operated animals, compared to 47 per cent in the intact treated mice. Contrary to LAF1 mice, in DBA/2 mice only a slight decrease in mammary tumour development was observed-57 per cent in the operated mice, compared to 78 per cent in the intact mice. Similar effects on the further development of the preneoplastic induced lesions in LAF1 and DBA/2 mice were obtained whether the mice were ovariectomized and adxenalectomized or only ovariectomized. The latent period of tumour development in DBA/2 mice was significantly shorter than in LAF1 mice (Fig. 1) . These results indicate that the concurrent treatment of mammary gland stimulation and carcinogen induce autonomous preneoplastic lesions in DBA /2 mice, whereas the preneoplastic lesions in LAF1 mice are dependent on the function of the ovaries for their further neoplastic transformation.
81S
The persistence of the preneoplkstic lesions Preneoplastic lesions were induced in LAF1 mice, after which the animals were ovariectomized. A third of these mice were regrafted 12 weeks later with one ovary beneath the right kidney capsule. (The functioning of the implant was checked by studying the vaginal smears of these mice. This revealed again the typical oestrus cycle for this strain, whereas the control ovariectomized mice showed a continuous dioestrus cycle.) As seen in Table IV hibited mammary tumour development from the induced preneoplastic lesions. The reimplantation of one ovary affected these initiated preneoplastic dependent lesions-20 per cent of these mice developed mammary tumours, compared to a 4'6 per cent tumour incidence in ovariectomized hosts carrying such preneoplastic lesions (Table IV and Fig. 1 ). Another group of ovariectomized mice, in wlhich preneoplastic lesions were induced, was grafted after a 3-month interval with a functioning mammotropic pituitary tumour secreting prolactin and growth hormone (Furth. Gadsden. Clifton and Anderson, 1956 ). This treatment failed to enhance the growth of the preneoplastic lesions: no mammary tumours developed in this group (Table  IV) .
)ISCUSSION A certain degree of mammary gland stimulation is known to be essential for mammary tumour development, with oestrogens playing a major role in stimulating mammary gland proliferation through its influence on the pituitary mammotropes. The primary difference between mouse strains exhibiting a low and high mammary tumour incidence may lie in the available hormones. especially oestrogens? capable of causing stimulation and nodule formationi in the mammary tissue. T'he proliferating mammary gland cells are a more favourable substrate for methylcholanthrene penetration (Dao. Bock and Crouch, 1959) . Comparing the vaginal smears of LAF, and DBA 2 mice, the more regular oestrus cycle of 1)BA 2 mice would suggest a normal level of oestrogen secretion, stimulating the mammary glands, which would allow mammary tumours to arise after methylcholanthrene application, whereas the LAF, mice. with the irregular oestrus cycle.
could explain the refractoriness of the poorly stimulating mammary tissue (lacking the nodules) to methylcholanthrene treatment.
In the present experiment, once the preneoplastic transformationi was induced.
the continuation or discontinuation of mammary gland stimulation failed to 1S -change significantly the tumour incidence or its latency. Mammary gland stimulation seemed therefore of importance mainly in the initiation of mammarv tumour induction in mice, rather than in promoting tumour development. Continuous mammary gland stimulation by subcutaneous isografts of hypophyses has been showni to lead to mammary tumour development (Loeb and Kirtz, 1939: Miihlbock and Boot, 1959) . In the present experiments similar observationis were obtained in mice carrying the intrarenal hypophvsis implant throughout life or for a limited period of 6 months.
I'he induced preneoplastic lesions were found to be autonomous lesions in IDBA 2 mice, progressing to malignant autonomous tumours in ovariectomized aind adreinalectomized mice. but dependeiit on ovarian hormones for further developmeint to autonomous mammary tumours in LAF1 mice. The shorter latenit period of mammary tumour development in DBA,,2 mice also indicated the more favourable " inherited " hormonal influence (Bittner, 1942) 
